Headway monetizing outcomes and access
Headway
The real opportunity is for Headway to move from being paid only when a therapy visit happens to being paid for proving that care actually worked. If Headway can turn symptom and functional improvement into a standard score that payers trust, it can sell two things at once, provider access and outcome reporting. That makes the platform more valuable to Medicare Advantage plans and commercial insurers that want behavioral health programs tied to lower total medical spend and measurable improvement.
-
This works because Headway already sits inside the care flow. Primary care referrals launched in May 2025 through existing EHR systems, and pilots produced 10,000 referrals from 15,000 physicians. Once referrals, sessions, and follow up assessments live in one system, Headway can show which patients improved, how fast, and after how many visits.
-
Comparable platforms are building the same bridge from therapy marketplace to outcomes infrastructure. Rula already collects PHQ-9 and GAD-7 before visits and positions that data for value based payer contracts. Alma also uses automated PHQ-9 and GAD-7 assessments and frames structured outcomes data as a path to software and payer revenue beyond claims take rates.
-
The payer demand side is becoming more concrete. CMS has long paid for behavioral health integration and collaborative care services, and in the CY 2026 Medicare physician fee schedule proposed rule CMS went further by proposing add on codes that would support primary care models paired with behavioral health integration. At the same time, NQF is launching outcomes driven certification built around standardized outcome measures and benchmarking, which makes payer grade reporting more commercially useful.
If Headway becomes the system that both routes patients from primary care and grades whether treatment changed symptoms or functioning, it can deepen from network vendor into payer infrastructure. That points toward contracts where Headway is rewarded for access, follow through, and improvement, and toward a new analytics line sold to plans that need proof their behavioral health spend is working.